Detalhe da pesquisa
1.
MRD dynamics during maintenance for improved prognostication of 1280 patients with myeloma in the TOURMALINE-MM3 and -MM4 trials.
Blood
; 141(6): 579-591, 2023 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36130300
2.
Ponatinib vs Imatinib in Frontline Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.
JAMA
; 331(21): 1814-1823, 2024 06 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38722621
3.
Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the PACE and OPTIC trials.
Leukemia
; 38(3): 475-481, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38287132
4.
Response-Based Dosing for Ponatinib: Model-Based Analyses of the Dose-Ranging OPTIC Study.
Clin Pharmacol Ther
; 114(2): 413-422, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37219378
5.
A pooled analysis of outcomes according to cytogenetic abnormalities in patients receiving ixazomib- vs placebo-based therapy for multiple myeloma.
Blood Cancer J
; 13(1): 14, 2023 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36631458
6.
Ixazomib Versus Placebo as Postinduction Maintenance Therapy in Newly Diagnosed Multiple Myeloma Patients: An Analysis by Age and Frailty Status of the TOURMALINE-MM4 Study.
Clin Lymphoma Myeloma Leuk
; 23(7): 491-504, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37149398
7.
Oral ixazomib-dexamethasone vs oral pomalidomide-dexamethasone for lenalidomide-refractory, proteasome inhibitor-exposed multiple myeloma: a randomized Phase 2 trial.
Blood Cancer J
; 12(1): 9, 2022 01 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35075109
8.
Ixazomib as Postinduction Maintenance for Patients With Newly Diagnosed Multiple Myeloma Not Undergoing Autologous Stem Cell Transplantation: The Phase III TOURMALINE-MM4 Trial.
J Clin Oncol
; 38(34): 4030-4041, 2020 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33021870
9.
Human immunodeficiency virus infection and chronic myeloid leukemia.
Leuk Res
; 36(11): 1334-8, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22867899